iCoreConnect Inc. (ICCT)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
iCoreConnect Inc. (ICCT) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Die Aktie erzielt 55/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 15. März 2026iCoreConnect Inc. (ICCT) Gesundheitswesen & Pipeline-Uebersicht
iCoreConnect Inc. delivers HIPAA-compliant SaaS solutions for the healthcare industry, focusing on electronic prescriptions, insurance verification, and secure communication. With a negative profit margin and OTC market listing, the company faces challenges in a competitive landscape dominated by larger, more established players.
Investmentthese
iCoreConnect operates in the growing healthcare information technology sector, offering a suite of HIPAA-compliant SaaS solutions. Key value drivers include the increasing adoption of electronic health records and the need for secure communication and data management in healthcare. However, the company's negative profit margin of -314.8% and OTC market listing present significant risks. Growth catalysts include expanding the customer base and introducing new product offerings. The company's ability to achieve profitability and gain market share in a competitive landscape will be critical to its long-term success.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- iCoreConnect Inc. operates in the Healthcare Information Services industry, providing cloud-based SaaS solutions.
- The company's gross margin stands at 72.1%, indicating a strong ability to control the direct costs associated with its services.
- iCoreConnect has a negative P/E ratio of -0.00, reflecting its current lack of profitability.
- The company's profit margin is -314.8%, indicating significant losses relative to its revenue.
- iCoreConnect operates with 67 employees, reflecting its relatively small size compared to larger competitors.
Wettbewerber & Vergleichsunternehmen
Staerken
- HIPAA-compliant solutions.
- Integrated suite of products.
- Established presence in the healthcare IT market.
- Specialized expertise in healthcare regulatory compliance.
Schwaechen
- Negative profit margin.
- Limited financial resources.
- Small market capitalization.
- OTC market listing.
Katalysatoren
- Upcoming: Potential new partnerships with EHR vendors to expand market reach.
- Ongoing: Increasing adoption of electronic health records and telehealth solutions.
- Ongoing: Growing demand for HIPAA-compliant data security solutions in healthcare.
Risiken
- Potential: Intense competition from larger, more established players in the healthcare IT market.
- Potential: Evolving healthcare regulations and compliance requirements.
- Ongoing: Negative profit margin and limited financial resources.
- Ongoing: OTC market listing and associated risks.
Wachstumschancen
- Expansion of iCoreVerify and iCoreVerify+ adoption: The market for automated insurance eligibility verification is growing as healthcare providers seek to reduce claim denials and improve revenue cycle management. iCoreConnect can capitalize on this trend by expanding the features of iCoreVerify and targeting larger healthcare organizations. The market size for healthcare revenue cycle management is projected to reach $107.9 billion by 2029.
- Increased adoption of iCoreExchange: With growing concerns about data privacy and security, the demand for HIPAA-compliant email solutions is increasing. iCoreConnect can promote iCoreExchange as a secure alternative to traditional email for healthcare professionals, targeting practices that handle sensitive patient information. The global healthcare cybersecurity market is projected to reach $38.5 billion by 2027.
- Strategic partnerships with EHR vendors: Collaborating with established EHR vendors to integrate iCoreConnect's solutions into their platforms can provide access to a wider customer base and accelerate adoption. This strategy can leverage the existing infrastructure and relationships of EHR vendors to expand iCoreConnect's market reach.
- Development of new SaaS solutions: Expanding the product portfolio with new SaaS solutions that address emerging needs in the healthcare industry can drive revenue growth and attract new customers. Potential areas for expansion include telehealth platforms, remote patient monitoring solutions, and data analytics tools for healthcare providers.
- Geographic expansion: While currently focused on the United States, iCoreConnect can explore opportunities to expand its operations into other countries with similar healthcare regulations and market needs. This expansion can be achieved through partnerships with local distributors or by establishing a direct presence in new markets.
Chancen
- Expansion of telehealth and remote patient monitoring.
- Growing demand for data security and privacy solutions.
- Strategic partnerships with EHR vendors.
- Development of new SaaS solutions for healthcare providers.
Risiken
- Intense competition from larger, more established players.
- Evolving healthcare regulations.
- Cybersecurity threats and data breaches.
- Economic downturn and reduced healthcare spending.
Wettbewerbsvorteile
- HIPAA compliance: iCoreConnect's focus on HIPAA compliance provides a competitive advantage in the healthcare industry, where data security and privacy are critical.
- Integrated suite of solutions: The company offers a range of integrated solutions that address various needs of healthcare providers, creating a stickier customer base.
- Established customer base: iCoreConnect has an existing customer base that provides a foundation for future growth.
- Specialized expertise: The company has specialized expertise in healthcare IT and regulatory compliance.
Ueber ICCT
Founded in 1992 and rebranded as iCoreConnect Inc. in 2017, the company offers a suite of cloud-based software solutions designed to address the specific needs of healthcare professionals. Their flagship products include iCoreRx, an electronic prescription software, and iCoreVerify, an insurance eligibility verification tool. iCoreConnect also provides solutions for prescription drug monitoring (iCorePDMP), secure email communication (iCoreExchange), cloud data backup (iCoreCloud), claims processing (iCoreClaims), and patient payment processing (iCorePay). iCoreConnect operates primarily in the United States, targeting healthcare providers seeking to improve efficiency and compliance with HIPAA regulations. The company's solutions aim to streamline administrative tasks, enhance patient care coordination, and improve revenue cycle management for healthcare practices.
Was das Unternehmen tut
- Provides HIPAA-compliant electronic prescription software (iCoreRx).
- Offers a solution to check patient prescription drug history (iCorePDMP).
- Provides automated insurance eligibility verification (iCoreVerify and iCoreVerify+).
- Offers a tool to reveal the revenue potential of each patient (iCoreHuddle and iCoreHuddle+).
- Provides a medical coding reference SaaS solution (iCoreCodeGenius).
- Offers a secure email solution for healthcare professionals (iCoreExchange).
- Provides cloud data backup services (iCoreCloud).
- Offers claims processing and management solutions (iCoreClaims).
Geschaeftsmodell
- SaaS subscriptions: iCoreConnect generates revenue through recurring subscription fees for its various software solutions.
- Per-transaction fees: Some services, such as claims processing and payment processing, may involve per-transaction fees.
- Managed IT services: iCoreIT provides managed IT services to healthcare practices, generating revenue through service contracts.
- Partnerships: Revenue may be generated through strategic partnerships with other healthcare technology vendors.
Branchenkontext
iCoreConnect operates within the healthcare information technology (IT) sector, which is experiencing significant growth driven by the increasing adoption of electronic health records (EHRs), the need for improved data security and compliance, and the growing demand for telehealth solutions. The market is competitive, with established players like ACNV (Accenture), CGHC (Cerner), EVLO (Evolus), HLTT (Hlth Corp), and INFIQ offering a range of healthcare IT solutions. iCoreConnect focuses on providing HIPAA-compliant SaaS solutions for specific healthcare needs, such as electronic prescriptions and insurance verification.
Wichtige Kunden
- Small to medium-sized healthcare practices.
- Dental practices.
- Physicians and specialists.
- Hospitals and clinics.
Finanzdaten
Chart & Info
iCoreConnect Inc. (ICCT) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
benzinga · 11. Apr. 2024
-
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
benzinga · 21. Dez. 2023
-
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
benzinga · 21. Dez. 2023
-
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
benzinga · 18. Dez. 2023
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ICCT.
Kursziele
Wall-Street-Kurszielanalyse fuer ICCT.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von ICCT auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Wettbewerber & Vergleichsunternehmen
Aktuelle Nachrichten
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Fuehrung: Adam V. Chambers
CEO
Adam V. Chambers serves as the Chief Executive Officer of iCoreConnect Inc. His professional background and educational details are not available in the provided context. Further research would be required to provide a comprehensive overview of his career history, previous roles, and credentials.
Erfolgsbilanz: Information regarding Adam V. Chambers' specific achievements, strategic decisions, and company milestones during his tenure as CEO of iCoreConnect Inc. is not available in the provided context. Further research would be required to assess his track record and contributions to the company's performance.
ICCT OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that iCoreConnect Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue and profitability trends.
- Review the company's legal and regulatory compliance.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Company has been in business since 1992.
- Offers a suite of HIPAA-compliant software solutions.
- Focuses on a specific niche within the healthcare IT market.
- Operates in a regulated industry (healthcare).
Was Anleger ueber iCoreConnect Inc. (ICCT) wissen wollen
What are the key factors to evaluate for ICCT?
iCoreConnect Inc. (ICCT) currently holds an AI score of 55/100, indicating moderate score. Key strength: HIPAA-compliant solutions.. Primary risk to monitor: Potential: Intense competition from larger, more established players in the healthcare IT market.. This is not financial advice.
How frequently does ICCT data refresh on this page?
ICCT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ICCT's recent stock price performance?
Recent price movement in iCoreConnect Inc. (ICCT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: HIPAA-compliant solutions.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ICCT overvalued or undervalued right now?
Determining whether iCoreConnect Inc. (ICCT) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ICCT?
Before investing in iCoreConnect Inc. (ICCT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding ICCT to a portfolio?
Potential reasons to consider iCoreConnect Inc. (ICCT) depend on individual investment goals and risk tolerance. A key strength identified by analysis: HIPAA-compliant solutions.. Additionally: Integrated suite of products.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of ICCT?
Yes, most major brokerages offer fractional shares of iCoreConnect Inc. (ICCT) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track ICCT's earnings and financial reports?
iCoreConnect Inc. (ICCT) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ICCT earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on the most recent available information.
- OTC market data may be limited or less reliable than data for major exchanges.
- AI analysis is pending and will provide further insights into the company's prospects.